US3867929A - Ultrasonic treatment device and methods for using the same - Google Patents
Ultrasonic treatment device and methods for using the same Download PDFInfo
- Publication number
- US3867929A US3867929A US021235A US2123570A US3867929A US 3867929 A US3867929 A US 3867929A US 021235 A US021235 A US 021235A US 2123570 A US2123570 A US 2123570A US 3867929 A US3867929 A US 3867929A
- Authority
- US
- United States
- Prior art keywords
- pain
- treatment
- bath
- edema
- frequency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 11
- 238000009210 therapy by ultrasound Methods 0.000 title description 3
- 238000011282 treatment Methods 0.000 claims abstract description 142
- 206010052428 Wound Diseases 0.000 claims abstract description 35
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 22
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 230000010355 oscillation Effects 0.000 claims abstract description 21
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 15
- 208000027418 Wounds and injury Diseases 0.000 claims description 17
- 238000004140 cleaning Methods 0.000 claims description 10
- 241001465754 Metazoa Species 0.000 abstract description 5
- 208000023178 Musculoskeletal disease Diseases 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 description 139
- 206010030113 Oedema Diseases 0.000 description 78
- 210000002683 foot Anatomy 0.000 description 50
- 208000024891 symptom Diseases 0.000 description 36
- 230000033001 locomotion Effects 0.000 description 30
- 206010006811 Bursitis Diseases 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 210000001872 metatarsal bone Anatomy 0.000 description 14
- 238000003745 diagnosis Methods 0.000 description 12
- 238000002203 pretreatment Methods 0.000 description 12
- 208000010040 Sprains and Strains Diseases 0.000 description 11
- 208000034656 Contusions Diseases 0.000 description 10
- 210000003423 ankle Anatomy 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 208000035475 disorder Diseases 0.000 description 10
- 206010017076 Fracture Diseases 0.000 description 9
- 206010024453 Ligament sprain Diseases 0.000 description 9
- 206010043255 Tendonitis Diseases 0.000 description 9
- 230000009519 contusion Effects 0.000 description 9
- 201000008482 osteoarthritis Diseases 0.000 description 9
- 210000003371 toe Anatomy 0.000 description 8
- 206010015150 Erythema Diseases 0.000 description 7
- 231100000321 erythema Toxicity 0.000 description 7
- 201000010934 exostosis Diseases 0.000 description 7
- 206010031149 Osteitis Diseases 0.000 description 5
- 201000009859 Osteochondrosis Diseases 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 206010006585 Bunion Diseases 0.000 description 4
- 208000006735 Periostitis Diseases 0.000 description 4
- 208000004760 Tenosynovitis Diseases 0.000 description 4
- 230000002146 bilateral effect Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000001255 hallux Anatomy 0.000 description 4
- 208000007427 heel spur Diseases 0.000 description 4
- YSGQGNQWBLYHPE-CFUSNLFHSA-N (7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2[C@H](C)CC3=CC(=O)CC[C@@H]3[C@H]21 YSGQGNQWBLYHPE-CFUSNLFHSA-N 0.000 description 3
- 206010033425 Pain in extremity Diseases 0.000 description 3
- 208000000491 Tendinopathy Diseases 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 238000001804 debridement Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 210000003195 fascia Anatomy 0.000 description 3
- 201000004415 tendinitis Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 208000000094 Chronic Pain Diseases 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 206010061159 Foot deformity Diseases 0.000 description 2
- 208000002472 Morton Neuroma Diseases 0.000 description 2
- 208000020059 Morton neuralgia Diseases 0.000 description 2
- 208000025740 Tailor Bunion Diseases 0.000 description 2
- 240000007591 Tilia tomentosa Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 230000036185 rubor Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 208000010884 Bursa disease Diseases 0.000 description 1
- 241000777300 Congiopodidae Species 0.000 description 1
- 241000896693 Disa Species 0.000 description 1
- 206010016228 Fasciitis Diseases 0.000 description 1
- 208000001963 Hallux Valgus Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 101100118976 Mus musculus Clint1 gene Proteins 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 101150097527 PARN gene Proteins 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241001016288 Sesamoides Species 0.000 description 1
- 208000008206 Talipes Cavus Diseases 0.000 description 1
- 208000023835 Tendon disease Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 229910002113 barium titanate Inorganic materials 0.000 description 1
- JRPBQTZRNDNNOP-UHFFFAOYSA-N barium titanate Chemical compound [Ba+2].[Ba+2].[O-][Ti]([O-])([O-])[O-] JRPBQTZRNDNNOP-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 210000004744 fore-foot Anatomy 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000000824 sesamoid bone Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000004341 tarsal joint Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000000431 third toe Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
- A61H23/0245—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with ultrasonic transducers, e.g. piezoelectric
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Devices For Medical Bathing And Washing (AREA)
Abstract
A therapeutic bath has ultrasonic acoustic transducers around the outer surface thereof, which uniformly oscillate a liquid within the bath. A part of the body suffering from a musculoskeletal disorder is placed in the bath. The power of the oscillations is adjusted to the individual patient. The liquid may include a medication to simultaneously treat and clean an open wound. Treatment is applicable to both humans and animals.
Description
UIIllZefl blales Patent AU :1: 2A
Joyner et al.
ULTRASONIC TREATMENT DEVICE AND METHODS FOR USING THE SAME lnventors: Bobby L. Joyner, Spring Mills; Betty L. Yearick, Howard; Harold S. Kaiser; James W. Anderson, both of State College, all of Pa.
Linden Laboratories, Inc., State College, Pa.
Filed: Mar. 20, 1970 Appl. No.: 21,235
Assignee:
US. Cl. 128/66, 128/24 A Int. Cl A6lh 9/00 Field of Search 128/24 A, 65, 66, 172, 128/1721 References Cited UNITED STATES PATENTS 1/1961 Prange l28/24 A 1 Feb. 25, 1975 3,499,436 3/1970 Balamuth l28/24A Primary Examiner-Lawrence W. Trapp Attorney, Agent, or Firm-Wenderoth, Lind and Ponack [57] ABSTRACT A therapeutic bath has ultrasonic acoustic transducers around the outer surface thereof, which uniformly oscillate a liquid within the bath. A part of the body suffering from a musculoskeletal disorder is placed in the bath. The power of the oscillations is adjusted to the individual patient. The liquid may include a medication to simultaneously treat and clean an open wound. Treatment is applicable to both humans and animals.
8 Claims, 3 Drawing Figures PATENTEBFEBZSISYS 5 N m w N mfiR E R E V YUAD 0 K L L W L m wmmm Wm OEAA AA BBHJ m8 L U VARIABLE POWER CONTROL FIG.I
POWER CONTROL FREQUENCY OSCI LLA TOR I ELECTRDNIC CIRCUIT MYRON E. SERVICK ATTORNEYS FIGZ 1 i ULTRASONIC TREATMENT DEVICE AND METHODS FOR USING THE SAME BACKGROUND OF THE INVENTION The present invention relates to an ultrasonic therapeutic treatment system. More specifically, the present invention relates to therapeutic treatment for relieving symptoms of certain musculoskeletal conditions of humans an animals. Furthermore specifically, the present invention relates to the therapeutic treatment of open wounds. Even more specifically, the present invention relates to such treatment by means of an ultrasonic bath, whereby the entire bath is subject to ultrasonic oscillations and the power of the ultrasonic oscillations is variable to adapt to the individual patient.
In the past there has been a great need for relieving symptoms of a number of musculoskeletal disorders, such as periostitis, contusions, sprains, strains, sesamoiditis, apophysitis, bunions, callousitis, tenosynovitis, various types of arthritis such as osteo arthritis, calcaneal spurs, neuralgia, fractures and bursitis. A number of attempts have been made in the past to develop therapeutic treatments for relieving the symptoms of certain of these disorders.
One form of such a prior art treatment involves a system to apply vibrations directly or through a coupling such as grease to parts of the body. However, such a treatment has a very limited degree of application and success. A later form of treatment comprises a therapeutic bath with a transducer located within the bath. However, this form of treatment also met with limited application and success. A primary problem with this system is that the oscillations are made uneven throughout the bath, and therefore the effect of the treatment varied greatly within the bath. All of the above methods of treatment suffer from certain inherent disadvantages in addition to the above listed disadvantages. Each patient is subjected to the same treatment. However, it has been found that each patient is not susceptible to the same treatment. This is due to differences in bone structure, skin flesh density, water content, and other musculoskeletal traits of the individual.
With thesedisadvantages in mind, it is an object of the present invention to provide therapeutic treatment to relieve the symptoms of certain musculoskeletal disorders, which treatment provides vastly improved results over the above-mentioned prior art treatments.
Furthermore, it is an object of the present invention to provide such treatment having a much greater field of application that prior art treatments.
Additionally, it is an object of the present invention to provide therapeutic treatment which is adaptable to the individual needs and limitations of each patient.
It is still a further object of the present invention to provide such a therapeutic treatment to relieve the symptoms of certain disorders in both humans and in animals.
It is to be understood that the scope of the present invention includes the treatment of all musculoskeletal disorders. For instance, the present invention encompasses the treatment of bone disorders such as fractures, and also disorders which relate to and effect bones such as calcaneal spurs and apophysitis. The present invention also encompasses the treatment of all types of muscle disorders such as contusions, membrane disorders such as periostitis, skin disorders such as callousitis, tendon disorders such as tenosynovitis, and bursa disorders such as bursitis and bunions. Furthermore, the present invention encompasses the treatment of disorders relating to and/or effecting bone and muscle, cartilage, ligament or nerve such as sprains, strains, sesamoiditis, various types of arthritis such as osteo arthritis and Mortons neuralgia.
These objects are achieved in accordance with the present invention by ultrasonically vibrating a therapeutic bath by means of ultrasonic acoustical transducers attached to the outside of the bath. This enables the entire bath to be uniformly oscillated. Such oscillations provide therapeutic relief of the symptoms of certain disorders. Means are provided to vary the power of the oscillations over a wide range. This variation of power allows each treatment to be adapted to the individual musculoskeletal limitations of the patient. Therefore, the conditions of treatment for each patient may be adjusted to provide the most effective treatment. This treatment will relieve the symptoms of certain musculoskeletal conditions in humans, and also in horses, cattle, dogs, cats and other similar livestock and pets.
Similarly, in the past there has been a great need for a method of debridement whereby open wounds may be cleaned and treated simultaneously. In the past. such therapeutic treatment and cleaning has consisted of a meticulous surgical debridement, such as wiping or sponging the open wound with a medication. However, it has been difficult by the use of such treatment to remove implanted dirt and debris from the wound.
Therefore, it is a further object of the present invention to provide a vastly improved therapeutic treatment of open wounds.
Such objects are achieved in accordance with the present invention by providing a medication in the ultrasonic bath. The ultrasonic bath performs cleaning of the wound, and simultaneously applies medication to the wound. The power of the bath is variable to adapt both to the limitations of each patient, and also to the severity of the particular wound.
Additionally, the present invention provides such a cleaning and therapeutic treatment whereby an acoustically transparent container surrounds the open wound, and contains medication which is in contact with the open wound. The wound and the container are then placed within the bath. Simultaneous cleaning and medication are performed in a similar manner as previously described.
Other objects and features of the invention will be made clear by the following description, taken together with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a schematic diagram of a therapeutic treatment device in accordance with the present invention;
FIG. 2 is a diagram of a perferred portable therapeutic treatment unit in accordance with the present invention; and
FIG. 3 is a diagram, partly in section, of a modified embodiment of the present invention for use in the simultaneous treatment and cleaning of open wounds.
With reference now to the drawings, a device will be described which will conveniently be used to perform the treatment of the present invention. In FIG. 1 is shown a bath 1 which is susceptible to ultrasonic oscillation. Around the outer surface of the bath 1 are provided a plurality of ultrasonic transducers 2. Transducers 2 are connected in a known manner through frequency oscillator 4 to an AC source 3. When power is supplied from source 3 to ultrasonic transducers 2, the liquid within the bath 1 is uniformly oscillated at a desired power and frequency. In order to adapt the power of the oscillations to the individual patients, variable power control 5 is provided in the control circuit. Control device 5 may be any such known device, or any commercially available such device. They are connected within the circuit in a known manner. By the provision of the control element 5, the power of the oscillation of the bath may be independently controlled and adjusted.
With reference now to FIG. 2, an example ofa practical device embodying the present invention is shown. The treatment device described with reference to FIG. 1 is conveniently mounted in a portable cart generally indicated at 10. Cart includes handle 11 and wheels 12 for portable movement. Bath 1, having transducers 2 mounted on the outer surface thereof, is conveniently and conventionally mounted within cart 10. Electronic power and control circuit 6, which includes frequency oscillator 4 and variable power control 5, is also conveniently mounted on cart 10.
It is to be understood that the practical embodiments of the present invention may be other than that specifically shown in FIG. 2. For instance, the cart 10 may have a different shape than that shown. Furthermore, the device may be mounted permanently rather than in a portable unit.
Furthermore, it is to be understood that the bath 1 may be of various shapes and adapted to receive various limbs and parts of the body undergoing treatment. For instance, the bath 1 may be particularly shaped to receive a foot, or a leg, or a hand, or an arm, or an elbow. Thus, it is to be seen that the scope of the present invention includes more than the diagrammatic shape of bath 1 shown in the figures.
Furthermore, it is to be understood that the present invention may include variable control units of a known type. For instance, as mentioned above, the frequency oscillator and transducers may be any which are commercially available and known in the art, for instance of polycrystalline ceramic material such as barium titanate or zirconium titanate. One example is the Sono" type, manufactured by Linden Laboratorles.
The variable power control may be any which is known and commercially available in the art. One such example is the Powerstat (7.5 amps/l00l40V) manufactured by Superior Electric Co., of Springfield, Ill.
The operation of the above device will now be described. The part of the body which is to undergo treatment is comfortably placed within the bath. The transducers cause the liquid in the bath to oscillate, whereby acoustic energy is conveyed throughout the liquid in the bath and the part of the body within the bath. A sufficient number of transducers are used to insure that the energy is uniformly conveyed throughout the liquid in the bath and the part of the body within the bath at the desired power level.
It has generally been found that the greater the energy applied to the part of the body undergoing treatment, the more successful will be the treatment. Thus, the variable power control is then adjusted to raise the power level as high as possible. When the power reaches the level at which there appears discomfort to the patient, the power level is slightly reduced. The practical range of power depends upon the patient, and may vary a great deal up to, for instance, a level of 10 watt per square centimeter of skin within the bath. However, it has been found that the most practical range is from 0.30 to 0.70 Watt/cm of skin within the bath.
The frequency of oscillation of the acoustic energy may be set at any desired level, usually within the range of 50 to 250 kilocycles. A particularly effective setting is I00 kc, with a tolerance of: 20 kc. Thus, according to this embodiment, the oscillator would be designed for lOO kc, and within commercial tolerances would oscillate at a frequency in the range of from to I20 kc.
The time length of each treatment may practically range from 3 or 4 minutes up to 10 minutes or more. It has been found that the treatment embodying the present invention is effective very rapidly. It has also been found that usually after 10 minutes of treatment, no additional benefits accrue. The number of treatments necessary vary a great deal, and depend on the individual patient, on the particular condition being treated, and upon the severity of the symptoms of the condition. It has been found that satisfactory results may occur after only a single treatment. It has also been found that good results have required as many as eleven treatments. It is conceivable of course, that relief of symptoms may take more than eleven treatments.
The composition of the bath may include any liquid which is sensitive to the transmission of acoustical energy, and which may be beneficial to the treatment of the particular condition. Water alone may be used, or various aqueous, oil or wax solutions may be used.
The temperature of the bath is not critical, although it has been found generally that warmer temperatures are helpful. The main consideration would be the comfort of the patient.
EXAMPLE I A patient suffering from a condition medically diagnosed as periostitis tibial tuberosity at the ankle, an old injury, was treated in accordance with the present invention. The patient, prior to treatment, suffered pain upon contact with shoes, or upon digital pressure. The ankle was placed in a bath in accordance with the present invention. The power was adjusted to 0.46 Watt/cm of skin with in the bath. This was found to be the maximum acceptable comfortable limit for this patient. The frequency of the ultrasonic oscillations was between 80 and kilocycles. The treatment was continued for 10 minutes. Two treatments such as described were performed on the patient. After the second treatment, the pain was completely gone and the patient could walk and wear shoes without pain.
A further patient was treated for symptoms of a similar condition in accordance with the present invention. The results are summarized in Table l.
TABLE 1 PRE-TREATMENT SYMPTOMS OF POWER 0 FRE- LENGTH OF NO. OF EFFECT OF UENCY MEDICAL CONDITION WATT/cm (KC) TREAT- TREAT- TREATMENT MENT MENTS DIAGNOSIS (MIN) ON SYMPTOMS Periostits Navi- Pain upon 0.49-0.57 80 to 90 8 9 Pain subsided pressure and cular right foot upon motion Thus it is shown that treatment in accordance with the present invention is successful in the relief of symptoms of periostitis.
Thus, it is seen that treatment in accordance with the present invention significantly relieves the symptoms of severe contusions.
EXAMPLE 2 EXAMPLE 3 A patient suffering from a condition medically diag- A patient suffering from a condition medically diagnosed as contusion of the first metatarso-phalangeal nosed as right ankle sprain was treated in accordance joint was treated in accordance with the present invenwith the present invention. The symptoms of the pation. The patient evidenced pain and edema and retients condition included massive edema, ecchymosis, stricted motion. The particular joint was placed in the weight bearing very painful. The power was adjusted to ultrasonic bath as above described. Power was adjusted 0.57 Watt/ 2 after the patient's ankle was placed in to 0.37 Watt/cm? The frequency of the ultrasonic 05- the bath. The frequency of the oscillations was between cillations was between 80 and 90 kilocycles. The length 80 to 90 kilocycles. Each treatment lasted 8 minutes. of each treatment was l0 minutes. Three treatments 5 Seven treatments were conducted, and after the sevwere given, and at the end of the third treatment the enth treatment, the edema had been reduced, there was pain and edema had subsided and motion was comno pain on locomotion, and the ecchymosis had been pletely restored. absorbed. Other patients suffering from similar condi- Other patients suffering from similar contusions untions were treated in accordance with the present inderwent similar treatment, the results of which are vention. The results of these treatments are s'ummasummarized in Table 2. rized in Table 3.
TABLE 2 PRE-TREATMENT SYMPTOMS OF POWER ogllzlfiby LENGTH OF NO. OF EFFECT OF MEDICAL C ONDlTlON WATT/cm (KC) TR EAT- TREAT- TREATM ENT MENT MENTS DIAGNOSIS (MIN) ON SYMPTOMS Severe Contusion Pain upon walking 0.55 to 90 8 i 5 Pain complete- Lt. Heel l absent Severe Contusion Pain and edema 0.57 80 to 90 I0 2 ain ceased 5th toe right foot and reduction of edema Severe Contusion Ecchimosis and 0.57 5 2 Absorption of of foot pain as well edema and disas edema appearance of ecchimosis Contusion-second. third constant pain 0.57 80 to 5 6 Complete aband fourth metatarsal and edema sence of pain and edema. No sensitivity anywhere in foot Contused Sesamoid Bone Pain at ball of 0.52 80 to 90 8 5 Edema subsided.
foot great toe joint Pain reduced to on weight bearnegative except ing. Edema of when walking area (left foot barefooted. only) Change of weather noticeably in area of condition treated Contusion severe Edema-Extensive- 0.57 80 to 90 8 6 Edema and 2nd, 3rd and 4th Pain on pain subsided Metatarsal head contact with area right food shoe and digital pressure TABLE 3 PRE-TREATMENT SYMPTOMS OF POWER LENGTH OF NO. OF EFFECT OF Y MEDICAL CONDITION WATT/cm (KC) TREQT- TREATMENTS TREATMENT ME T DIAGNOSIS (MIN) ON SYMPTOMS Sprain mid-tarsal area Pain on weight AQSMIQOfPIin right foot bearing limited 0.61 80-90 8 3 motion normal motion Sprain rt. lst carpal Pain no power 0.55 80-90 10 5 Pain eased to metacarpal jt. in grip point of occasion twinge Chronic sprain left constant ache Free from pain and sensitiv- 0.66 80-90 8-l0 S ity Sprain midtarsal Pain on pres- Absence of pain joints sure and edema 0.41 8090 I0 3 and reduction of edema completely Chronic sprain of rt. Pain and edema ankle on standing 0.69 80-90 8-10 4 N0 edema, pain completely relieved. Function excellent Sprain right ankle Pain and Edema Pain and Edema (lateral right ankle 0.49-0.57 80-90 l0 7 subsided.
Walking is Patient walked possible with without cane a cane. after 2nd treatment Sprain midtarsal area Pain causing Edema subsided. right foot limp upon 0.53-0.57 80-90 10 3 Pain eliminated walking and pain on any pressure. Edema at instep Sprain left ankle Edema-Ecchymo- Edema subsidedsis extensive Motion unrestricextremely 0.66 80-90 10 5 led-ECChyII'lOSIS limited motion faded in One week Thus, it is seen that the treatment of sprains, in accordance with the present invention, significantly eliminates the symptoms of such conditions.
EXAMPLE 4 A patient suffering from a condition medically diagnosed as post-poliomyelitis plantar fascia strain of the right foot was treated in accordance with the present invention. The symptoms of the condition were severe pain and edema, patient almost nonambulatory. The patients foot was placed in a bath in accordance with the present invention. The power level was adjusted to 0.55 Watt/ 2 and the frequency of oscillations was between 80 to 90 kc. The time length of each treatment was 8-l0 minutes. After the end of the sixth treatment, the pain and edema had disappeared.
Similar treatments were conducted on patients suffering from similar conditions. Results of these treatements are summarized in Table 4.
Thus it is seen that treatment in accordance with the present invention relieves the symptoms of strains.
EXAMPLE 5 A patient suffering from a condition medically diagnosed as sesamoiditis of the left foot was treated in accordance with the present invention. The symptoms of the condition were chronic pain and edema. The foot was placed in a bath in accordance with the present invention as described above. The power level was ad- .justed to 0.64 Watt 2, and the frequency of oscillations was between to kc. The length of each treatment was 8-l0 minutes. After the end of the fourth treatment, the pain was gone and the edema was completely absorbed.
Patients suffering from similar conditions were treated in accordance with the present invention. The results of these treatments are summarized in Table 5.
TABLE 4 PRE-TREATMENT SYMPTOMS OF POWER LENGTH OF NO. OF EFFECT OF MEDICAL CONDITION WATT/cm (KC) TREIQT- TREATMENTS TREATMENT ME T DIAGNOSIS (MIN) ON SYMPTOMS Plantar fascia strain; Pain on standresult of pes cavus ing and walk- 0.49 80-90 8-I0 7 Absence of edema ing. Edema edema completely. Freedom from pain cornmix. Chronic Plantar Fascia Extreme pain 0.4l0.49 8090 8 8 Pain subsided strain (Fascitis) both upon any use Activities feet of feet (Athletic resumed) TABLE 5 PRE-TREATMENT SYMPTOMS OF POWER LENGTH OF NO. OF EFFECT OF MEDICAL CONDITION WATT/cm (KC) Tb??? TREATMENTS TREATMENT DIAGNOSIS (MIN) ON SYMPTOMS Sesamoiditis left foot Unable to bear Pain freefirst Metatarsal head weight on fore- 0.6l 80-90 I0 4 weightbearing foot pain on normal motion flexion and unrestricted extension Sesamoiditis(Bifurcated) Pain at ball Pain on extenright foot of foot upon 0.57-0.61 80-90 8 9 sion ceased standing and walking and upon extension of great toe Sesamoiditis(Bifurcated) Pain on stand- Pain subsided right foot ing or exten- 0.57-0.6l 80-90 8 7 motion was norsion of great mal and paintoe less Thus, it is seen that treatment in accordance with the present invention relieves the symptoms of sesamoid- A patient suffering from a condition medically diagnosed as apophysitis of the left heel was treated in accordance with the present invention. The symptoms of the condition were pain on weight bearing and upon physical activities. The heel was placed in the bath in accordance with the present invention. The power level was varied between 0.49 and 0.53 Watt/ 2, and the frequency was between 80 to 90 kc. The length of each treatment was 8 minutes, and after the end of the third treatment the pain had subsided.
A further patient suffering from a similar condition was treated in accordance with the present invention. The results of such treatment are summarized in Table 6.
Thus it is seen that the symptoms of bunions may be relieved by the employment of treatment in accordance with the present invention.
EXAMPLE 8 A patient suffering from a condition medically diagnosed as multiple callousitis bilateral was treated in accordance with the present invention. Symptoms of the condition were pain at metatarsal areas of both feet. The feet were placed in a bath and the power was adjusted to from 0.59 to 0.61 Watt/m2- The frequency of oscillation was between 80 and 90 kc. The length of each treatment was 8 minutes. At the end of the third treatment, the inflammation had been reduced. The ache, however, although decreased, remained present, due to the foot structure of the patient.
Thus it is seen that treatment in accordance with the present invention is successful in relieving symptoms of callousitis.
TABLE. 6
PRE-TREATMENT SYMPTOMS POWER 0 LENGTH OF NO. OF EFFECT OF OF MEDICAL CONDITION WATT/cm (KC) Riga";- TREATMENTS TREATMENT DIAGNOSIS (MIN) ON SYMPTOMS Apophysitis left Pain on walkheel ing'and runn- 0.49-0.55 80-90 8 5 Pain upon walking and on ing ceased. Runndigital presing was forbidsure den Thus, it is seen that treatment in accordance with the EXAMPLE 9 present invention is successful in relieving the symptoms of apophysitis.
EXAMPLE 7 A patient suffering from a condition medically diagnosed at Tailors bunion of the left foot, head of the fifth metatarsal, was treated in accordance with the present invention. The symptoms were edema and erythema, right 5th metatarsal head. The foot was placed in a bath and the power level was adjusted to 0.53 to 0.61 Watt Z. The frequency of oscillations was between 80 to 90 kc. Each treatment last 8 minutes. At the end of the fourth treatment, the pain has subsided. The enlarged joint however, being bone, did not decrease.
A patient suffering from a condition medically diagnosed as tendonitis posterial tibial muscle of the right foot was treated in accordance with the present invention. The symptoms of the condition were pain upon motion, motion restricted. The foot was placed in a bath in accordance with the present invention. The power level was adjusted to 0.52 Watt/m2, and the frequency was between and kc. Each treatment lasted 10 minutes. At the end of the fourth treatment, the pain had disappeared, and motion was completely unrestricted.
Patients suffering from conditions similar to that above were treated in accordance with the present invention. The results of these treatments are summarized in Table 7.
TABLE 7 PRE-TREATMENT SYMPTOMS OF POWER LENGTH OF NO. OF EFFECT OF MEDICAL CONDITION WATT/cm (KC) TLIZEA T- TREATMENTS TREATMENT EN DIAGNOSIS (MIN) ON SYMPTOMS Tendonitis-Extensor Pain on motion Hallucis Lon us left extension and 0.43-0.6I 80-90 I0 6 Pain subsidedfoot Hallux algus left flexion of Motion returned foot great toe left to normal and foot pain free Chronic Hallux Valgus Pain in shoes Edema reducedright foot and Erythema 0.57 80-90 8 pain eliminated of area Tenosynovitis right Pain on exten- Pain completely foot-extensor Hallugis sion of great 0.55 80-90 8 8 absent. Motion Longus Mosue toe rightfoot unlimited upon either active or passive motion. Range of motion limited due to pain Tenosynovitis right Extreme pain on tendon achilles motion Edema in 0.53-0.70 80-90 8 7 Pain and Edema ankle area Thus it is seen that treatment in accordance with the present invention is successful in relieving symptoms of tendonitis and similar conditions.
EXAMPLE 10 A patient suffering from a condition medically diagnosed as osteo arthritis of both feet was treated in accordance with the present invention. Symptoms of the subsided condition were pain and edema in joint areas, stiffness and limited motion. Both feet were placed in the bath been decreased, and motion was increased.
Other patients suffering from similar conditions were treated in accordance with the present invention. The results of these treatments are summarized in Table 8.
TABLE 8 PRE-TREATMENT SYMPTOMS OF POWER LENGTH OF NO. OF EFFECT OF MEDICAL CONDITION WATT/cm (KC) TREQT- TREATMENTS TREATMENT M T DIAGNOSIS (MIN) ON SYMPTOMS Osteo Arthritis both Pain upon walkfeet Metatarsal Phalaning Edema 0.55 -90 l0 4 No pain Reeal area chronic duction of Edema allux Valgns (right) Pain-intermitchronic Edema tent edema 0.57 80-90 8-10 4 Pain decreased.
No edema Osteo Arthritis Phalan- Pain on digigeal Metatarsal joints tal pressure 0.53-0.59 80-90 8 4 Pain subsided and bilateral and when standache disappeared ing for short periods Osteo Arthritis right Patient felt ain ankle Pain and ach- 0.57-0.61 80-90 I0 2 ache had su sided ing after walkand further treating or standing ment wasn't necessary Osteo Arthritis mid Pain upon Pain subsided Tarsal joints bilaterwalking and 0.49-0.52 80-90 8 5 upon walking g,| standing Arthritis-2nd right Pain on pres- Metatarsal sure (lateral) or 0.59 80-90 8 5 Motion unrestricdorsal) flexted and pain free. ion and exten- Edema absorbed sion Edema Osteo Arthritis-Digital Pain and Edema both feet Pain on motion 0.49 80-90 I0 5 and when resubsided tired Edema of toes Osteo Arthritis both Pain on walkfeet ing and stand- 0.49-0.57 80-90 8 6 Pain decreased ing to point of comfort EXAMPLE I l A patient suffering from a condition medically diagnosed as calcaneal spur of the left foot was treated in accordance with the present invention. Symptoms of the condition were pain upon walking and pain upon standing after rest. The foot was placed in the bath and the power was adjusted to 0.46 Watt/cm? The frequency was between 80-90 kc. The length of each treatment was 10 minutes. At the end of the sixth treatment, the pain had completely subsided.
Patients suffering from similar conditions were treated in accordance with the present invention. The results of these treatments are summarized in Table 9.
nosed as Morton Neuralgia bilateral was treated in accordance with the present invention. Symptoms of the condition were pain after wearing shoes. The feet were placed in a bath and the power level was adjusted to 0.66 Watt/cm. Frequency was between 80-90 kc. The length of each treatment was 8-l0 minutes. At the end of the third treatment, the pain had decreased.
Thus, it is seen that treatment in accordance with the present invention is successful in relieving the symptoms of neuralgia.
EXAMPLE 13 A patient suffering from a condition medically diagnosed as fracture proximal phalanx of the left third toe was treated in accordance with the present invention. Symptoms of the condition were pain and edema upon TABLE 9 PRE-TREATMENT SYMPTOMS POWER LENGTH OF NO. OF EFFECT OF OF MEDICAL CONDITION WATT/cm (KC) TREATMENTS TREATMENT DIAGNOSIS (MIN) ON SYMPTOMS Bitaleral Calcaneal Extreme pain on 0.46 80-90 l0 ll Pain subsided. spurs standing and walking and especially after standing proresting v rd es no sensitrvrty Plantar calcaneal spur Pain on digital pressure 0.62 80-90 8-10 4 Pain subsided and weightand heel aches bearing only after extensive walking Calcaneal spur( left) Pain on stand- I ing.walking, 0.62 80-90 8-l 0 6 Pain subsided. and digital and recurs only pressure periodically afler extended standing or walk- Calcaneal spur lefl Pain upon standfoot ing and walk- 0.57 80-90 10 7 Pain subsided and ing walking and standcreates no discomfort Calcaneal spur right Pain-needle 0.53 80-90 8 increas- 5 Pain subsided foot Plantarly sharp upon ed to l0 and symptom free standing or walking Calcaneal spurs- Pain upon aris- Plantarly both feet ing and on walk- 0.52 80-90 8 8 Pain subsided.
ing or stand- Walks with ease. mg Bilateral Calcaneal Pain upon arisspur Plantarly ing and walking 0.66 80-90 8-l0 6 Parn ceased or standing Calcaneal spur-Plan- Standing and tarly both feet walking caused 0.64 80-90 l0 6 Pam subsided extreme pain after 2nd treatment and patient was Pain free after completion of 6th treatment Calcaneal spur left Pain on walk- Pain eased No foot plantarly ing or standing 0.57 80-90 8 5 pain when arisespecially upon mg, walking is arising comfortable Thus, it is seen that treatment in accordance with the weight bearing. The foot was placed in a bath and the power level was adjusted to 0.46 Watt/cm. The frequency was between 80 and 90 kc. The length of each treatment was 8-10 minutes. At the end of the sixth treatment, the edema had been absorbed, and the pain has subsided. The patient was able to ambulate.
present invention is successful in relieving the symptoms of calcaneal spurs.
} EXAMPLE 12 A patient suffering from a condition medically diag- Patients suffering from similar conditions were area of the left foot was treated in accordance with the treated in accordance with the present invention. The present invention. The symptoms of the condition w results of these treatments are summarized in Table 10. P n digital pressu e. nd ight edema. The foot was TABLE I PRE-TREATMENT SYMPTOMS OF POWER LENGTH OF NO. OF EFFECT OF 0 CY MEDICAL CONDITION WATT/cm (KC) TREAT- TREATMENTS TREATMENT MENT DIAGNOSIS (MIN) ON SYMPTOMS Fracture th toe(right) Pain on pres- 0.6l 80-90 8-10 Edema reduced. three wks. 01d. Pain sure and when No pain while and edema waIking.Edema wearing footgear or when walking Post fracture Fibrosis Pain on weight and Edema of ankle. bearing. Edema 0.53 80-90 Ankle has motion. Left loss of motion(exafter walking. Fibrosis distension and flexion) Lack of mosolved. Edema tion even with eliminated and passive exerpain free cise Fracture Proximal Pain on weight Phalanx 4th toebearing and 0.52 80-90 8 Edema subsided- Duration 3 weeks Edema Pain absent Fracture,Proximal Pha- Pain upon flex- Pain subsidedlanx right 4th toe ion and exten- 0.55 80-90 8 able to ambulate sion painlessly Transverse fracture 5th Pain on prespain subsided toe right foot Prox. sure either shoe 0.57 80-90 8 Phalanx or digital condition has been present for 2 weeks prior to treatment placed in the bath, and the power level was adjusted to 0.53 Watt/cm". The frequency was between 80-90 kc.
The length of each treatment was 8 minutes. At the end of the fourth treatment, all pain and edema had subsided.
EXAMPLE Patients suffering from similar conditions were A pati t suffering from a condition medically diagtreated in accordance with the present invention. The
nosed as adventitious bursitis metatarsal phalangeal results of these treatments are summarized in Table II.
Thus it is seen that treatment in accordance with the present invention is successful in relieving the symptoms of fractures.
TABLE II PRE-TREATMENT SYMPTOMS OF POWER LENGTH OF NO. OF EFFECT OF MEDICAL CONDITION WATT/cm (KC) Riggs;- TREATMENTS TREATMENT DIAGNOSIS (MIN) 0N SYMPTOMS Bursitis-Head of 5th Pain and Edema 0.61 -90 8 6 Pain.Edema and Metatarsal Lt(Tailor of Area. Erthema Absol- Bunion) Erythema ved Bursitis-Navicular Pain when wear- Tubercle Lt. Foot 8 shoe or 0.49 80-90 8 4 Edema and pain slipper.Edema subsided. and Erythema Slight erythema present but area was generally normal Bursitis sesamoid Edema and ex- 0.32 80-90 8-10 3 Absorption of right first metatarsal treme pain on edema and comhead weight-bearing plete absence of pain Adventitious Bursitis Pain on walking right foot Mctatarso- Edema at the base 0.62 80-90 10 4 Edema subsided- Phalangeal joints of the toes pain subsided Bursitis front metatar- Pain on walksal head of first metaing or runn- 0.32 80-90 8-10 3 Pain subsided tarsal ing on activity Posterior Calcaneal Pain on shoe Bursitis right foot pressure as 0.70 80-90 8 5 Pain subsided well as digital pressure Bursitis 5th toe left Pain upon foot beneath Kerotosed wearing any 0.57-0.61 80-90 8 6 Pain and Edema tissue and Edema shoe subsidedShoe no longer caused pain TABLE -Qmtfiusi PRE-TREATMENT SYMPTOMS OF POWER FRE- LENGTH OF NO. OF EFFECT OF UENCY MEDICAL CONDITION WATT/cm (KC) ThIlEAT TREATMENTS TREATMENT ENT DIAGNOSIS (MIN) ON SYMPTOMS Bursitis right foot lst Pain when flex- Metatarsal joint ing foot or 0.66 80-90 8 6 Pain free-Endigital preslargement did sure not reduce Bursitis-left calcaneal Chronic pain Edema subsided area Posterior or flexion or 0.41-0.49 80-90 8 Pain ceased on extension with motion or presshoe on-Edema sure Bursitis right achilles Pain on motion Motion is paintendon (flexion and ex- 0.32-0.41 80-90 8 5 less and full tension of foot) motion freely accomplished Posterior Calcaneal Pain and Edema Bursitis left foot left foot 0.49-0.52 80-90 8 6 Pain and Edema absorbed Bursitis-right foot Extreme pain,
5th Metatarsal head Erythema and 0.49-0.57 80-90 l0 5 Pain-Edema and Edema Erythema eliminated Adventitious Bursitis- Pain -extreme 0.57-0.67 80-90 10 4 Pain subsided- Metatarso-Phalangeal upon standing Edema absorbed joints both feet or walking.
Edema of forefoot Bursitis right 5th meta- Edema-slight Pain free and tarsal head(known also and pain when 0.57 80-90 10 3 Edema absorbed as Tailors Bunion) wearing shoes Posterior Calcaneal Bur- Pain-Constant 8 to l0 sitis-Bilateral and severe 0.49 80-90 gradually 9 Edema and Rubor Edema and Rubor increased absorbed and pain of the area completely subsided. Shoes again could be worn comfortably Thus it is seen that treatment in accordance with the present invention is successful in relieving the symptoms of bursitis.
The present invention is furthermore applicable to the treatment of other similar disorders than those specifically mentioned. Additionally, although the above examples all involve the treatment of humans. it is to be understood that the scope of the present invention encompasses the treatment of similar disorders in horses, cattle, dogs, cats and other livestock and pets. For instance, it is to be understood that a race horse suffering from a sprained knee joint could readily be treated in accordance with the present invention. This example is not meant to be limiting, however, since it is further to be understood that virtually any animal could be treated for any of the above specific disorders or similar related disorders.
It is also to be understood that the scope of the present invention encompasses the simultaneous treatment and cleaning of open wounds. As previously discussed there are great practical difficulties in thoroughly cleaning and treating open wounds. For instance, it is difficult by mere surgical debridement such as wiping or sponging of the wound to eliminate all debris or dirt therefrom. However, by employing the concept of the present invention, an open wound no matter how severe and dirty may be cleaned and treated simultaneously. Furthermore, such treatment and cleaning may be carried out more thoroughly and quickly than by any previously known method.
For instance, in this embodiment of the invention the liquid used in the bath shown in FIGS. 1 and 2 may include a medication. As the bath is ultrasonically vibrated, the wound in cleaned and simultaneously the medication is applied. The power of the ultrasonic vibrations is adjusted as described above. However, in addition to the discomfort of the patient, other limitations of the power include the severity of the wound and the amount of debris and dirt in the wound.
Often times, however, it may not be desirable to subject the open wound to the liquid bath. This may be for hygienic reasons. Therefore, in accordance with a further embodiment of the present invention. the advantages of the present treatment may be retained while isolating the open wound from the liquid in the bath. As shown in FIG. 3, open wound 20 is surrounded by an acoustically transparent container 21. Container 21 contains medication 22 which surrounds and covers wound 20 and which is also acoustically transparent. Container 21 may be made of any convenient material, the only requirement being that it be capable of transmitting acoustic vibrations. Examples of such material are polyethylene or polypropylene from 3-I0 mils thick. The limb with the wound and the container are placed together in the bath. Treatment is then performed as described above. The ultrasonic oscillations are transmitted from the bath through container 21 and medication 22 to simultaneously clean and treat wound 20.
Although several embodiments of the invention have been described in detail, such description is intended to be illustrative only, since many details of the performance and construction of the invention may be altered or modified without departing from the spirit or scope thereof.
What is claimed is:
l. A therapeutic treatment device comprising a bath adapted to contain a therapeutic liquid; at least one acoustic transducer means attached to said bath for conveying uniform acoustic energy through said liquid at a uniform ultrasonic frequency; means operatively connected to said transducer means to selectively adjust the power of said energy to a uniform level up to L Watt/square centimeter of surface being treated within said liquid; and an acoustically transparent container adapted to contain a medication and surround an open wound, and adapted to be immersed in said liquid.
2. A device as claimed in claim 1, wherein said transducer oscillates at a frequency in the range of from 50 to 250 kilocycles.
and adjusting means are mounted on a movable cart, whereby said device is portable.
6. A method for the simultaneous treatment and cleaning of an open wound of a patient comprising placing said wound in a solution containing a medication within an acoustically transparent container surrounding said wound; placing said container in an ultrasonically oscillating bath; conveying uniform acoustic energy at a uniform ultrasonic frequency from said ultrasonically oscillating bath through said container and to said solution; and selectively adjusting the power of said energy up to the maximum comfort level of said patient while maintaining said uniform frequency, said level being no higher than 1.0 Watt/square centimeter of surface being treated in said bath.
7. A method as claimed in claim 6, wherein said frequency of said oscillations is in the range of from 50 to 250 kilocycles.
Claims (8)
1. A therapeutic treatment device comprising a bath adapted to contain a therapeutic liquid; at least one acoustic transducer means attached to said bath for conveying uniform acoustic energy through said liquid at a uniform ultrasonic frequency; means operatively connected to said transducer means to selectively adjust the power of said energy to a uniform level up to 1.0 Watt/square centimeter of surface being treated within said liquid; and an acoustically transparent container adapted to contain a medication and surround an open wound, and adapted to be immersed in said liquid.
2. A device as claimed in claim 1, wherein said transducer oscillates at a frequency in the range of from 50 to 250 kilocycles.
3. A device as claimed in claim 1, wherein said transducer oscillates at a frequency of 100 + or - 20 kilocycles, and said means for adjusting power is variable between 0.30 and 0.70 Watt per square centimeter of surface within said liquid.
4. A device as claimed in claim 1, wherein said bath is adapted in shape and size to accomodate the part of the body undergoing therapeutic treatment.
5. A device as claimed in claim 1, wherein said bath and adjusting means are mounted on a movable cart, whereby said device is portable.
6. A method for the simultaneous treatment and cleaning of an open wound of a patient comprising placing said wound in a solution containing a medication within an acoustically transparent container surrounding said wound; placing said container in an ultrasonically oscillating bath; conveying uniform acoustic energy at a uniform ultrasonic frequency from said ultrasonically oscillating bath through said container and to said solution; and selectively adjusting the power of said energy up to the maximum comfort level of said patient while maintaining said uniform frequency, said level being no higher than 1.0 Watt/square centimeter of surface being treated in said bath.
7. A method as claimed in claim 6, wherein said frequency of said oscillations is in the range of from 50 to 250 kilocycles.
8. A method as claimed in claim 6, wherein said power is raised to from 0.30 to 0.70 Watt square centimeter of the surface of the body of said patient within said solution And the frequency of said oscillations is 100 + or - 20 kilocycles.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US021235A US3867929A (en) | 1970-03-20 | 1970-03-20 | Ultrasonic treatment device and methods for using the same |
GB1297369D GB1297369A (en) | 1970-03-20 | 1970-05-04 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US021235A US3867929A (en) | 1970-03-20 | 1970-03-20 | Ultrasonic treatment device and methods for using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
US3867929A true US3867929A (en) | 1975-02-25 |
Family
ID=21803115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US021235A Expired - Lifetime US3867929A (en) | 1970-03-20 | 1970-03-20 | Ultrasonic treatment device and methods for using the same |
Country Status (2)
Country | Link |
---|---|
US (1) | US3867929A (en) |
GB (1) | GB1297369A (en) |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4073289A (en) * | 1976-04-30 | 1978-02-14 | Fahim Mostafa S | Method of male contraception for domestic mammals having a scrotum |
US4077401A (en) * | 1976-04-06 | 1978-03-07 | Fahim Mostafa S | Suppression of spermatogenesis |
US4078556A (en) * | 1976-04-06 | 1978-03-14 | Fahim Mostafa S | Apparatus useful in suppression of spermatogenesis |
US4185502A (en) * | 1977-10-11 | 1980-01-29 | Ralph Frank | Transducer coupling apparatus |
US4390026A (en) * | 1981-05-22 | 1983-06-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Ultrasonic therapy applicator that measures dosage |
US4787888A (en) * | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US4820260A (en) * | 1986-11-10 | 1989-04-11 | Hayden Steven M | Method and apparatus for extravascular treatment of red blood cells |
US4942868A (en) * | 1988-03-30 | 1990-07-24 | Malmros Holding, Inc. | Ultrasonic treatment of animals |
US4945901A (en) * | 1989-03-22 | 1990-08-07 | Burcke Jr Harry J | Hand therapy apparatus and method therefor |
US5339804A (en) * | 1993-07-16 | 1994-08-23 | Amada Technologies Inc. | Ultrasonic bathing system |
US5665141A (en) * | 1988-03-30 | 1997-09-09 | Arjo Hospital Equipment Ab | Ultrasonic treatment process |
US5693004A (en) * | 1996-03-11 | 1997-12-02 | Lord Corporation | Controllable fluid rehabilitation device including a reservoir of fluid |
WO1999025256A1 (en) | 1995-06-15 | 1999-05-27 | Ostrow Alvin S | Submersive therapy apparatus |
US6074352A (en) * | 1998-03-26 | 2000-06-13 | Brigham And Women's Hospital | Method for the treatment of joint diseases characterized by unwanted pannus |
US20030171675A1 (en) * | 2000-08-03 | 2003-09-11 | Lior Rosenberg | System for enhanced chemical debridement |
US20050251068A1 (en) * | 2004-05-07 | 2005-11-10 | Amit Mor | Bone-growth stimulator |
US20060200006A1 (en) * | 2003-07-11 | 2006-09-07 | Catherine Drogin | Method and apparatus for conducting an oral examination on youthful patients |
US20060293630A1 (en) * | 2005-06-22 | 2006-12-28 | Misonix Incorporated | Fluid containment apparatus for surgery and method of use |
EP1797855A1 (en) * | 2005-12-13 | 2007-06-20 | TEUCO GUZZINI S.p.A. | Method and apparatus for moisturising skin using ultrasound |
US20070167882A1 (en) * | 2005-12-13 | 2007-07-19 | Mauro Guzzini | Cosmetic treatment and relative apparatus |
US20070232987A1 (en) * | 2006-02-22 | 2007-10-04 | Vicente Diaz | One-hand-operated ultrasound transducer and method for delivering a controlled and uniform distribution of a sterile or a non-sterile topical reagent to skin for use in diagnostic, therapeutic, and aesthetic therapies |
WO2008077096A2 (en) * | 2006-12-19 | 2008-06-26 | Cedars-Sinai Medical Center | Ultrasonic bath to increase tissue perfusion |
US20100211071A1 (en) * | 2009-02-13 | 2010-08-19 | Lettmann Jason W | Methods and devices for treating hallux valgus |
US20110077656A1 (en) * | 2009-09-25 | 2011-03-31 | Sand Paul M | Methods and devices for treating a structural bone and joint deformity |
US8353853B1 (en) * | 2003-01-24 | 2013-01-15 | Boston Scientific Scimed, Inc. | Encephalic insonication |
US8652141B2 (en) | 2010-01-21 | 2014-02-18 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
US8696719B2 (en) | 2010-06-03 | 2014-04-15 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
US20170065960A1 (en) * | 2014-03-13 | 2017-03-09 | Productos Agrovin, S.A. | Application of ultrasound in vinification processes |
US10744368B2 (en) | 2010-07-02 | 2020-08-18 | Apos Medical And Sports Technologies Ltd. | Device and methods for tuning a skeletal muscle |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080097252A1 (en) * | 2006-08-25 | 2008-04-24 | Eilaz Babaev | Ultrasound and Pressure Therapy Wound Care Device |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2970073A (en) * | 1959-10-28 | 1961-01-31 | Howe Sound Co | Method for ultrasonic surgical cleaning of human body members |
US3499436A (en) * | 1967-03-10 | 1970-03-10 | Ultrasonic Systems | Method and apparatus for treatment of organic structures with coherent elastic energy waves |
-
1970
- 1970-03-20 US US021235A patent/US3867929A/en not_active Expired - Lifetime
- 1970-05-04 GB GB1297369D patent/GB1297369A/en not_active Expired
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2970073A (en) * | 1959-10-28 | 1961-01-31 | Howe Sound Co | Method for ultrasonic surgical cleaning of human body members |
US3499436A (en) * | 1967-03-10 | 1970-03-10 | Ultrasonic Systems | Method and apparatus for treatment of organic structures with coherent elastic energy waves |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4077401A (en) * | 1976-04-06 | 1978-03-07 | Fahim Mostafa S | Suppression of spermatogenesis |
US4078556A (en) * | 1976-04-06 | 1978-03-14 | Fahim Mostafa S | Apparatus useful in suppression of spermatogenesis |
US4073289A (en) * | 1976-04-30 | 1978-02-14 | Fahim Mostafa S | Method of male contraception for domestic mammals having a scrotum |
US4185502A (en) * | 1977-10-11 | 1980-01-29 | Ralph Frank | Transducer coupling apparatus |
US4390026A (en) * | 1981-05-22 | 1983-06-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Ultrasonic therapy applicator that measures dosage |
US4820260A (en) * | 1986-11-10 | 1989-04-11 | Hayden Steven M | Method and apparatus for extravascular treatment of red blood cells |
US4787888A (en) * | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
EP0645131A3 (en) * | 1988-03-30 | 1995-11-15 | Malmros Holding Inc | Ultrasonic treatment of animals. |
US5665141A (en) * | 1988-03-30 | 1997-09-09 | Arjo Hospital Equipment Ab | Ultrasonic treatment process |
US4942868A (en) * | 1988-03-30 | 1990-07-24 | Malmros Holding, Inc. | Ultrasonic treatment of animals |
EP0645131A2 (en) * | 1988-03-30 | 1995-03-29 | Malmros Holding, Inc. | Ultrasonic treatment of animals |
EP0645130A2 (en) * | 1988-03-30 | 1995-03-29 | Malmros Holding, Inc. | Ultrasonic treatment of animals |
EP0645130A3 (en) * | 1988-03-30 | 1995-11-15 | Malmros Holding Inc | Ultrasonic treatment of animals. |
US4945901A (en) * | 1989-03-22 | 1990-08-07 | Burcke Jr Harry J | Hand therapy apparatus and method therefor |
US5339804A (en) * | 1993-07-16 | 1994-08-23 | Amada Technologies Inc. | Ultrasonic bathing system |
WO1999025256A1 (en) | 1995-06-15 | 1999-05-27 | Ostrow Alvin S | Submersive therapy apparatus |
US5693004A (en) * | 1996-03-11 | 1997-12-02 | Lord Corporation | Controllable fluid rehabilitation device including a reservoir of fluid |
US6074352A (en) * | 1998-03-26 | 2000-06-13 | Brigham And Women's Hospital | Method for the treatment of joint diseases characterized by unwanted pannus |
US7128719B2 (en) * | 2000-08-03 | 2006-10-31 | Mediwound Ltd. | System for enhanced chemical debridement |
US20030171675A1 (en) * | 2000-08-03 | 2003-09-11 | Lior Rosenberg | System for enhanced chemical debridement |
US8353853B1 (en) * | 2003-01-24 | 2013-01-15 | Boston Scientific Scimed, Inc. | Encephalic insonication |
US20060200006A1 (en) * | 2003-07-11 | 2006-09-07 | Catherine Drogin | Method and apparatus for conducting an oral examination on youthful patients |
US20050251068A1 (en) * | 2004-05-07 | 2005-11-10 | Amit Mor | Bone-growth stimulator |
US7462158B2 (en) * | 2004-05-07 | 2008-12-09 | Amit Mor | Bone-growth stimulator |
US20060293630A1 (en) * | 2005-06-22 | 2006-12-28 | Misonix Incorporated | Fluid containment apparatus for surgery and method of use |
WO2007001819A2 (en) * | 2005-06-22 | 2007-01-04 | Misonix Incorporated | Fluid containment apparatus for surgery and method of use |
WO2007001819A3 (en) * | 2005-06-22 | 2009-06-11 | Misonix Inc | Fluid containment apparatus for surgery and method of use |
EP1797855A1 (en) * | 2005-12-13 | 2007-06-20 | TEUCO GUZZINI S.p.A. | Method and apparatus for moisturising skin using ultrasound |
US20070167882A1 (en) * | 2005-12-13 | 2007-07-19 | Mauro Guzzini | Cosmetic treatment and relative apparatus |
US20070232987A1 (en) * | 2006-02-22 | 2007-10-04 | Vicente Diaz | One-hand-operated ultrasound transducer and method for delivering a controlled and uniform distribution of a sterile or a non-sterile topical reagent to skin for use in diagnostic, therapeutic, and aesthetic therapies |
WO2008077096A3 (en) * | 2006-12-19 | 2008-08-07 | Cedars Sinai Medical Center | Ultrasonic bath to increase tissue perfusion |
WO2008077096A2 (en) * | 2006-12-19 | 2008-06-26 | Cedars-Sinai Medical Center | Ultrasonic bath to increase tissue perfusion |
US20100063423A1 (en) * | 2006-12-19 | 2010-03-11 | Cedars-Sinai Medical Center | Ultrasonic bath to increase tissue perfusion |
US20150231416A1 (en) * | 2006-12-19 | 2015-08-20 | Board Of Regents Of The University Of Texas System | Ultrasonic bath to increase tissue perfusion |
US9050448B2 (en) * | 2006-12-19 | 2015-06-09 | Cedars-Sinai Medical Center | Ultrasonic bath to increase tissue perfusion |
US20100211071A1 (en) * | 2009-02-13 | 2010-08-19 | Lettmann Jason W | Methods and devices for treating hallux valgus |
US8870876B2 (en) | 2009-02-13 | 2014-10-28 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
US8795286B2 (en) | 2009-09-25 | 2014-08-05 | Tarsus Medical Inc. | Methods and devices for treating a structural bone and joint deformity |
US8277459B2 (en) | 2009-09-25 | 2012-10-02 | Tarsus Medical Inc. | Methods and devices for treating a structural bone and joint deformity |
US20110077656A1 (en) * | 2009-09-25 | 2011-03-31 | Sand Paul M | Methods and devices for treating a structural bone and joint deformity |
US8652141B2 (en) | 2010-01-21 | 2014-02-18 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
US8696719B2 (en) | 2010-06-03 | 2014-04-15 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
US10744368B2 (en) | 2010-07-02 | 2020-08-18 | Apos Medical And Sports Technologies Ltd. | Device and methods for tuning a skeletal muscle |
US11504571B2 (en) | 2010-07-02 | 2022-11-22 | Apos Medical Assets Ltd. | Device and methods for tuning a skeletal muscle |
US20170065960A1 (en) * | 2014-03-13 | 2017-03-09 | Productos Agrovin, S.A. | Application of ultrasound in vinification processes |
US20180221848A1 (en) * | 2014-03-13 | 2018-08-09 | Productos Agrovin, S.A. | Application of ultrasound in vinification processes |
US11045782B2 (en) * | 2014-03-13 | 2021-06-29 | Productos Agrovin, S.A. | Application of ultrasound in vinification processes |
US11052371B2 (en) * | 2014-03-13 | 2021-07-06 | Productos Agrovin, S.A. | Application of ultrasound in vinification processes |
Also Published As
Publication number | Publication date |
---|---|
GB1297369A (en) | 1972-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3867929A (en) | Ultrasonic treatment device and methods for using the same | |
Giudice | Effects of continuous passive motion and elevation on hand edema | |
US7806841B2 (en) | Non-ambulatory thermotherapy device for heat and cold therapy of the foot/ankle complex and hand/wrist complex | |
EP2863985B1 (en) | Device for increasing microcirculation | |
McCulloch | The role of physiotherapy in managing patients with wounds | |
Nicolopoulos et al. | Biomechanical basis of foot orthotic prescription | |
Santopietro | Foot and foot-related injuries in the young athlete | |
US20030181836A1 (en) | Device for relieving heel pain | |
Patrick | Ultrasound in physiotherapy | |
Walker et al. | Total-contact casting, sandals, and insoles: construction and applications in a total foot-care program | |
Macdonald et al. | Complications and management of the neurologically impaired foot | |
Keagy et al. | Severe avulsion injury of the lower extremity skin | |
Chinn et al. | The Role of Extracorporeal Pulse Activation Therapy on Pain Reduction With Peroneus Longus Tendinitis | |
DEHEER | The Non-Surgical Treatment of Equinus. | |
Scifers et al. | Extracorporeal shockwave therapy | |
RU2647830C1 (en) | Method of rehabilitation treatment of post-traumatic ankle joint contraction after fractures of shin bones | |
SU1174034A1 (en) | Functional and curative small boot | |
Lange | The orthopedic treatment of spinal paralysis | |
Müller | Some aspects of the management of orthopaedic cases in south-east Asia | |
SU1489763A1 (en) | Method of treating infantile cerebral paralysis | |
Guo-you | Treatment of 20 cases of ankle sprain with Tuina combined with physical therapy | |
Aufranc | Trimalleolar fracture of ankle | |
Nasef | Influence of acupuncture LASER on Achilles tendonitis | |
Kaneps | Shockwave therapy protocols for the horse. | |
Wiener | TREATMENT OF FRACTURES AND SPRAINS OF THE ANKLE BY MASSAGE |